JP2004505965A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004505965A5 JP2004505965A5 JP2002518202A JP2002518202A JP2004505965A5 JP 2004505965 A5 JP2004505965 A5 JP 2004505965A5 JP 2002518202 A JP2002518202 A JP 2002518202A JP 2002518202 A JP2002518202 A JP 2002518202A JP 2004505965 A5 JP2004505965 A5 JP 2004505965A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- compound
- formula
- salt
- hydrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 125000000217 alkyl group Chemical group 0.000 claims 21
- 150000001875 compounds Chemical class 0.000 claims 19
- 229910052739 hydrogen Inorganic materials 0.000 claims 8
- 239000001257 hydrogen Substances 0.000 claims 8
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 8
- 150000003839 salts Chemical class 0.000 claims 8
- 125000003545 alkoxy group Chemical group 0.000 claims 5
- 238000000034 method Methods 0.000 claims 2
- 125000001424 substituent group Chemical group 0.000 claims 2
- 239000002253 acid Substances 0.000 claims 1
- 229940100198 alkylating agent Drugs 0.000 claims 1
- 239000002168 alkylating agent Substances 0.000 claims 1
- 125000003277 amino group Chemical group 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00402257 | 2000-08-09 | ||
| PCT/GB2001/003561 WO2002012227A2 (en) | 2000-08-09 | 2001-08-08 | Indole, azaindole and indazole derivatives having vegf inhibiting activity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004505965A JP2004505965A (ja) | 2004-02-26 |
| JP2004505965A5 true JP2004505965A5 (enExample) | 2005-03-17 |
Family
ID=8173808
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002518202A Pending JP2004505965A (ja) | 2000-08-09 | 2001-08-08 | 化合物 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US20030207878A1 (enExample) |
| EP (1) | EP1311500A2 (enExample) |
| JP (1) | JP2004505965A (enExample) |
| KR (1) | KR20030029812A (enExample) |
| CN (1) | CN1245402C (enExample) |
| AU (2) | AU7993801A (enExample) |
| BR (1) | BR0113078A (enExample) |
| CA (1) | CA2416525A1 (enExample) |
| IL (1) | IL154034A0 (enExample) |
| MX (1) | MXPA03000874A (enExample) |
| NO (1) | NO20030628L (enExample) |
| NZ (1) | NZ523987A (enExample) |
| WO (1) | WO2002012227A2 (enExample) |
| ZA (1) | ZA200300489B (enExample) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100838617B1 (ko) | 1999-02-10 | 2008-06-16 | 아스트라제네카 아베 | 혈관형성 억제제로서의 퀴나졸린 유도체 |
| UA72946C2 (uk) * | 1999-11-05 | 2005-05-16 | Астразенека Аб | Похідні хіназоліну як інгібітори васкулярного ендотеліального фактора росту (vegf) |
| WO2001066099A2 (en) | 2000-03-06 | 2001-09-13 | Astrazeneca Ab | Use of quinazoline derivatives as angiogenesis inhibitors |
| DE60121931T2 (de) * | 2000-04-07 | 2007-03-01 | Astrazeneca Ab | Chinazolinverbindungen |
| AU2003202094B2 (en) | 2002-02-01 | 2009-10-08 | Astrazeneca Ab | Quinazoline compounds |
| TW200400034A (en) | 2002-05-20 | 2004-01-01 | Bristol Myers Squibb Co | Pyrazolo-pyrimidine aniline compounds useful as kinase inhibitors |
| TWI272271B (en) * | 2002-07-19 | 2007-02-01 | Bristol Myers Squibb Co | Process for preparing certain pyrrolotriazine compounds |
| TWI329112B (en) * | 2002-07-19 | 2010-08-21 | Bristol Myers Squibb Co | Novel inhibitors of kinases |
| KR20110050745A (ko) * | 2002-10-03 | 2011-05-16 | 탈자진 인코포레이티드 | 혈관항상성 유지제 및 그의 사용 방법 |
| SI1562955T1 (sl) | 2002-11-04 | 2008-06-30 | Astrazeneca Ab | Derivati kinazolina kot inhibitorji Src-triozin kinaze |
| US7109337B2 (en) | 2002-12-20 | 2006-09-19 | Pfizer Inc | Pyrimidine derivatives for the treatment of abnormal cell growth |
| RS20060097A (sr) | 2002-12-20 | 2008-11-28 | Pfizer Products Inc., | Derivati pirimidina za lečenje nekontrolisanog rasta ćelija |
| EP1601348A4 (en) | 2003-02-28 | 2008-12-10 | Oxigene Inc | Compositions and methods with improved therapeutic activity |
| WO2004103159A2 (en) * | 2003-05-14 | 2004-12-02 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for modulating endometrium |
| EP1756090A1 (en) | 2004-05-14 | 2007-02-28 | Pfizer Products Incorporated | Pyrimidine derivatives for the treatment of abnormal cell growth |
| JP2007537238A (ja) | 2004-05-14 | 2007-12-20 | ファイザー・プロダクツ・インク | 異常細胞増殖の治療のためのピリミジン誘導体 |
| BRPI0510980A (pt) | 2004-05-14 | 2007-11-27 | Pfizer Prod Inc | derivados de pirimidina para o tratamento do crescimento anormal de células |
| US7851623B2 (en) * | 2006-11-02 | 2010-12-14 | Astrazeneca Ab | Chemical process |
| US20080190689A1 (en) * | 2007-02-12 | 2008-08-14 | Ballard Ebbin C | Inserts for engine exhaust systems |
| CN104945311A (zh) | 2009-01-19 | 2015-09-30 | Abbvie公司 | 用于治疗癌症和免疫和自身免疫疾病的细胞程序死亡诱导药剂 |
| JP2012518640A (ja) * | 2009-02-23 | 2012-08-16 | メルク・シャープ・エンド・ドーム・コーポレイション | ピラゾロ［４，３−ｃ］シンノリン−３−オンＭ１受容体陽性アロステリックモジュレーター |
| US8653079B2 (en) | 2011-08-15 | 2014-02-18 | Merck Sharp & Dohme Corp. | Pyrazolo [4,3-C] cinnolin-3-one M1 receptor positive allosteric modulators |
| MX383300B (es) | 2014-06-19 | 2025-03-13 | Boehringer Ingelheim Animal Health Usa Inc | Composiciones parasiticidas que comprenden derivados de indol, metodos y usos de los mismos. |
| CA3140044A1 (en) * | 2019-05-14 | 2020-11-19 | The Scripps Research Institute | Compounds for the treatment of neurodegenerative and metabolic disorders |
| WO2021254529A1 (zh) * | 2020-07-14 | 2021-12-23 | 江苏先声药业有限公司 | 双环类化合物 |
| CA3213079A1 (en) | 2021-04-13 | 2022-10-20 | Kristin Lynne ANDREWS | Amino-substituted heterocycles for treating cancers with egfr mutations |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3987332A (en) * | 1975-10-09 | 1976-10-19 | Varian Associates | Gang tuner for multi-cavity klystron |
| US5480883A (en) * | 1991-05-10 | 1996-01-02 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase |
| US5237629A (en) * | 1992-03-19 | 1993-08-17 | The United States Of America As Represented By The United States Department Of Energy | Digitally controlled distributed phase shifter |
| US5440270A (en) * | 1992-07-14 | 1995-08-08 | Linear Technology Corporation | Linear-phase filter having high gain selectivity |
| SE500986C2 (sv) * | 1993-07-20 | 1994-10-17 | Telia Ab | Förfarande och anordning för synkronisering i digitalt transmissionssystem av typen OFDM |
| TW414798B (en) * | 1994-09-07 | 2000-12-11 | Thomae Gmbh Dr K | Pyrimido (5,4-d) pyrimidines, medicaments comprising these compounds, their use and processes for their preparation |
| US5639757A (en) * | 1995-05-23 | 1997-06-17 | Pfizer Inc. | 4-aminopyrrolo[2,3-d]pyrimidines as tyrosine kinase inhibitors |
| US6395733B1 (en) * | 1995-06-07 | 2002-05-28 | Pfizer Inc | Heterocyclic ring-fused pyrimidine derivatives |
| GB9604361D0 (en) * | 1996-02-29 | 1996-05-01 | Pharmacia Spa | 4-Substituted pyrrolopyrimidine compounds as tyrosine kinase inhibitors |
| JP3727406B2 (ja) * | 1996-03-07 | 2005-12-14 | 株式会社日立国際電気 | 関数変換演算器 |
| HRP970371A2 (en) * | 1996-07-13 | 1998-08-31 | Kathryn Jane Smith | Heterocyclic compounds |
| NZ334125A (en) * | 1996-09-25 | 2000-10-27 | Zeneca Ltd | Quinoline derivatives inhibiting the effect of growth factors such as VEGF |
| CO4950519A1 (es) * | 1997-02-13 | 2000-09-01 | Novartis Ag | Ftalazinas, preparaciones farmaceuticas que las comprenden y proceso para su preparacion |
| US6162804A (en) * | 1997-09-26 | 2000-12-19 | Merck & Co., Inc. | Tyrosine kinase inhibitors |
| HRP20000286A2 (en) * | 1997-11-11 | 2000-12-31 | Pfizer Prod Inc | Thienopyrimidine and thienopyridine derivatives useful as anticancer agents |
| JPH11259454A (ja) * | 1998-03-09 | 1999-09-24 | Sharp Corp | フーリエ変換装置 |
| EP1107964B8 (en) * | 1998-08-11 | 2010-04-07 | Novartis AG | Isoquinoline derivatives with angiogenesis inhibiting activity |
| US20030162795A1 (en) * | 1998-10-22 | 2003-08-28 | Pfizer Inc. | Thienopyrimidine and thienopyridine derivatives useful as anticancer agents |
| KR200212866Y1 (ko) * | 1998-12-26 | 2001-02-15 | 서평원 | 선왜곡 방식 전력증폭기용 능동 왜곡신호 발생회로 |
| US6982265B1 (en) * | 1999-05-21 | 2006-01-03 | Bristol Myers Squibb Company | Pyrrolotriazine inhibitors of kinases |
| CA2373990C (en) * | 1999-05-21 | 2007-05-08 | Bristol-Myers Squibb Company | Pyrrolotriazine inhibitors of kinases |
| GT200000158A (es) * | 1999-09-28 | 2002-03-16 | Piridinas y piridacinas sustituidas con actividad de inhibicion de angiogenesis. | |
| DE60106022T2 (de) * | 2000-06-06 | 2006-03-09 | Pfizer Products Inc., Groton | Thiophenverbindungen zur verwendung als antikrebsmittel |
-
2001
- 2001-08-08 CA CA002416525A patent/CA2416525A1/en not_active Abandoned
- 2001-08-08 IL IL15403401A patent/IL154034A0/xx unknown
- 2001-08-08 AU AU7993801A patent/AU7993801A/xx active Pending
- 2001-08-08 MX MXPA03000874A patent/MXPA03000874A/es not_active Application Discontinuation
- 2001-08-08 EP EP01958210A patent/EP1311500A2/en not_active Withdrawn
- 2001-08-08 CN CNB018166962A patent/CN1245402C/zh not_active Expired - Fee Related
- 2001-08-08 NZ NZ523987A patent/NZ523987A/en unknown
- 2001-08-08 AU AU2001279938A patent/AU2001279938B2/en not_active Ceased
- 2001-08-08 JP JP2002518202A patent/JP2004505965A/ja active Pending
- 2001-08-08 US US10/343,236 patent/US20030207878A1/en not_active Abandoned
- 2001-08-08 WO PCT/GB2001/003561 patent/WO2002012227A2/en not_active Ceased
- 2001-08-08 KR KR10-2003-7001852A patent/KR20030029812A/ko not_active Ceased
- 2001-08-08 BR BR0113078-1A patent/BR0113078A/pt not_active IP Right Cessation
-
2003
- 2003-01-17 ZA ZA200300489A patent/ZA200300489B/en unknown
- 2003-02-07 NO NO20030628A patent/NO20030628L/no not_active Application Discontinuation
-
2006
- 2006-02-16 US US11/355,006 patent/US20060148819A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004505965A5 (enExample) | ||
| CA2398682A1 (en) | Phosphonium and imidazolium salts and methods of their preparation | |
| JP2004533467A5 (enExample) | ||
| JP2006508903A5 (enExample) | ||
| JP2007523139A5 (enExample) | ||
| JP2005525427A5 (enExample) | ||
| EP1826196A3 (en) | Vinyl ether compounds | |
| JP2004535412A5 (enExample) | ||
| CA2549431A1 (en) | Optically active quaternary ammonium salt having axial asymmetry and process for producing .alpha.-amino acid and derivative thereof with the same | |
| UA86013C2 (ru) | Производные арилалкилкарбаматов, их получение и применение в лечении | |
| JPH09301934A5 (enExample) | ||
| JP2006523241A5 (enExample) | ||
| EP1849788A8 (en) | Organosilicon compound | |
| EP2088142A3 (en) | Dihydropyrimidines, process for their preparation and use thereof. | |
| JP2005519149A5 (enExample) | ||
| RU2006121438A (ru) | Способ получения бисфосфолановых лигандов | |
| JP2007538042A5 (enExample) | ||
| CA2334821A1 (en) | Chemical synthesis of morpholine derivatives | |
| JP2005526149A5 (enExample) | ||
| EP0357404A3 (en) | Process for the preparation of cyclopentane derivatives | |
| JP2006524231A5 (enExample) | ||
| JP2005508930A5 (enExample) | ||
| WO2003024958A3 (en) | Processes for the preparation of 1,5-diaryl-3-substituted-pyrazoles | |
| JP2005536557A5 (enExample) | ||
| JP2012530113A5 (enExample) |